Triple-negative breast cancer (TNBC), a molecular type of breast cancer with negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2), accounts for approximately 15 to 20% of all breast cancer cases [1–3]. This evidence concerns the gene PGR and breast cancer.